Cargando…

Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia

Acute myeloid leukemia (AML) may be an epigenetically-driven malignancy because it harbors fewer genomic mutations than other cancers. In recent studies of AML in adults, DNA methylation patterns associate with clinical risk groups and prognosis. However, thorough evaluations of methylation in pedia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamba, Jatinder K., Cao, Xueyuan, Raimondi, Susana C., Rafiee, Roya, Downing, James R., Lei, Shi, Gruber, Tanja, Ribeiro, Raul C., Rubnitz, Jeffrey E., Pounds, Stanley B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003565/ https://www.ncbi.nlm.nih.gov/pubmed/29928480 http://dx.doi.org/10.18632/oncotarget.25475

Ejemplares similares

Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia
por: Lamba, Jatinder K., et al.
Publicado: (2018)

A 6-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia
por: Elsayed, Abdelrahman H., et al.
Publicado: (2019)

DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML
por: Lamba, Jatinder K., et al.
Publicado: (2020)

Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML
por: Bargal, Salma A., et al.
Publicado: (2018)

Proteomics: a new era in pediatric acute myeloid leukemia research
por: Lamba, Jatinder K., et al.
Publicado: (2022)

MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia
por: Bhise, Neha S., et al.
Publicado: (2019)

Combination of Cladribine and Cytarabine is Effective for Childhood Acute Myeloid Leukemia: Results of the St. Jude AML97 Trial
por: Rubnitz, Jeffrey E., et al.
Publicado: (2009)

SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
por: Marrero, Richard J., et al.
Publicado: (2023)

CC-PROMISE effectively integrates two forms of molecular data with multiple biologically related endpoints
por: Cao, Xueyuan, et al.
Publicado: (2016)

Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML
por: Nguyen, Nam H. K., et al.
Publicado: (2022)

Global Proteomic Profiling of Pediatric AML: A Pilot Study
por: Nguyen, Nam H. K., et al.
Publicado: (2021)

DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia
por: Buelow, Daelynn R., et al.
Publicado: (2020)

Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia
por: Karol, Seth E., et al.
Publicado: (2023)

Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome
por: Iijima, Mayuko, et al.
Publicado: (2022)

MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients
por: Bhise, Neha S., et al.
Publicado: (2016)

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators
por: Fornerod, Maarten, et al.
Publicado: (2021)

ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children’s Oncology Group AAML0531 Trial
por: Rafiee, Roya, et al.
Publicado: (2019)

A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
por: Nguyen, Rosa, et al.
Publicado: (2019)

Current Landscape of Genome-Wide Association Studies in Acute Myeloid Leukemia: A Review
por: Marrero, Richard J., et al.
Publicado: (2023)

Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy
por: Pui, Ching-Hon, et al.
Publicado: (2016)

Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia
por: Zhou, Yujia, et al.
Publicado: (2020)

Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosis
por: Umeda, Masayuki, et al.
Publicado: (2023)

Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16
por: Gruber, Tanja A., et al.
Publicado: (2022)

Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
por: Stockard, Bradley, et al.
Publicado: (2018)

Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia
por: Xu, Huan, et al.
Publicado: (2022)

A Revised Definition for Cure of Childhood Acute Lymphoblastic Leukemia
por: Pui, CH, et al.
Publicado: (2014)

Role of Epigenetics in Chronic Myeloid Leukemia
por: Machova Polakova, Katerina, et al.
Publicado: (2013)

The Epigenetic Landscape of Acute Myeloid Leukemia
por: Conway O'Brien, Emma, et al.
Publicado: (2014)

Acute Myeloid Leukemia: Aging and Epigenetics
por: Zjablovskaja, Polina, et al.
Publicado: (2019)

Subgroup and outlier detection analysis
por: Wu, Gang, et al.
Publicado: (2013)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
por: Schwartz, Jason R., et al.
Publicado: (2021)

Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML
por: Stockard, Bradley, et al.
Publicado: (2021)

Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT 3‐ITD AML
por: Buelow, Daelynn R., et al.
Publicado: (2019)

Epigenetic treatment and beyond in acute myeloid leukemia
por: Wei, Andrew
Publicado: (2018)

Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia
por: Depreter, Barbara, et al.
Publicado: (2020)

Long-term results of St. Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
por: Pui, C-H, et al.
Publicado: (2009)

Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate
por: Das, Andrew B., et al.
Publicado: (2020)

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)

Epigenetic regulation of HOTAIR in advanced chronic myeloid leukemia
por: Li, Ziye, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_98d6demcsa3td4nn431carq9p0